NCAM1 and neoplasm: CD56(dim) NK cells use highly expressed CD16 to mediate antibody-dependent cell-mediated cytotoxicity (ADCC) to induce phosphorylation of immune receptor tyrosine activation motif (ITAM) and finally immunize and kill tumor cells [18].